Related Experiment Video
Updated: Jul 14, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Chronic interstitial lung disease in children
Maria Aparecida S S Paiva1, Sandra M M Amaral
1Hospital dos Servidores do Estado, Rio de Janeiro, RJ, Brazil. mariaaparecida.paiva@gmail.com
Jornal De Pediatria
|June 7, 2007
Summary
Chronic interstitial lung diseases in children are rare but can progress to pulmonary fibrosis. Early diagnosis and specialized, long-term care are crucial for better patient outcomes in pediatric pulmonology.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Pediatric Pathology
Background:
- Chronic interstitial lung disease (chILD) encompasses rare pediatric pulmonary disorders.
- These conditions carry a risk of progression to irreversible pulmonary fibrosis.
- Early recognition and management are vital for improving patient prognosis.
Purpose of the Study:
- To detail the clinical and diagnostic characteristics of pediatric chILD.
- To evaluate the therapeutic approaches and outcomes in affected children.
- To highlight the importance of specialized pediatric pulmonary care.
Main Methods:
- Retrospective analysis of 25 immunocompetent pediatric patients (2 months to 17 years) with chILD.
- Data collected over a 20-year period (1984-2004) from a dedicated Pediatric Pulmonary Section.
- Inclusion based on a protocol for persistent chronic pneumonias; analysis of clinical, laboratory, and imaging data.
Main Results:
- Diagnosis relied on invasive tests in 21/25 cases (lung biopsy or bronchoalveolar lavage).
- Treatment primarily involved corticosteroids, sometimes with hydroxychloroquine; 4 patients needed home oxygen.
- Outcomes included good (15), regular with mild sequelae (4), and poor with severe sequelae (3); 2 deaths occurred.
Conclusions:
- Pediatric chILD requires prompt diagnosis and sustained, expert management.
- Awareness among pediatricians is essential to avoid delayed diagnosis and treatment.
- Specialized follow-up care significantly impacts the long-term outlook for children with chILD.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.